Local drug makers to take severe beating
Published: 2011-11-25 07:00:00
Updated: 2011-11-25 07:00:00
The country’s pharmaceutical companies will face tough times ahead with the new Korea-U.S. Free Trade Agreement poised to strengthen patent rights for U.S. drug giants, heaping strain on the generic-focused Korean industry.
Defying strong protests from opposition parties, lawmakers, mostly fro...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
